Skip to main navigation
Go to Cumberland Pharmaceuticals, Inc. homepage
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
Contact
Contact

SEC Filings

Form Description Filer Filing Date View
10-Q Quarterly report which provides a continuing view of a company's financial position May 08, 2026
View HTML
0001087294-26-000049.pdf
0001087294-26-000049.rtf
0001087294-26-000049.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K Report of unscheduled material events or corporate event May 05, 2026
View HTML
0001087294-26-000046.pdf
0001087294-26-000046.rtf
0001087294-26-000046.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K Report of unscheduled material events or corporate event Apr 24, 2026
View HTML
0001087294-26-000043.pdf
0001087294-26-000043.rtf
0001087294-26-000043.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEFA14A Additional proxy soliciting materials - definitive Apr 23, 2026
View HTML
0001104659-26-047338.pdf
0001104659-26-047338.rtf
0001104659-26-047338.xls
8-K Report of unscheduled material events or corporate event Apr 23, 2026
View HTML
0001104659-26-047335.pdf
0001104659-26-047335.rtf
0001104659-26-047335.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
4 Statement of changes in beneficial ownership of securities BITTERMAN CHRIS T. Mar 20, 2026
View HTML
0001087294-26-000034.pdf
0001087294-26-000034.rtf
0001087294-26-000034.xls
4 Statement of changes in beneficial ownership of securities KAZIMI A J Mar 20, 2026
View HTML
0001087294-26-000032.pdf
0001087294-26-000032.rtf
0001087294-26-000032.xls
4 Statement of changes in beneficial ownership of securities HAMM JOHN M. Mar 20, 2026
View HTML
0001087294-26-000033.pdf
0001087294-26-000033.rtf
0001087294-26-000033.xls
4 Statement of changes in beneficial ownership of securities Herman James L Mar 20, 2026
View HTML
0001572342-26-000002.pdf
0001572342-26-000002.rtf
0001572342-26-000002.xls
4 Statement of changes in beneficial ownership of securities ANTHONY TODD M. Mar 20, 2026
View HTML
0001087294-26-000035.pdf
0001087294-26-000035.rtf
0001087294-26-000035.xls
Form: 10-Q
Description: Quarterly report which provides a continuing view of a company's financial position
May 08, 2026
View HTML
0001087294-26-000049.pdf
0001087294-26-000049.rtf
0001087294-26-000049.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: 8-K
Description: Report of unscheduled material events or corporate event
May 05, 2026
View HTML
0001087294-26-000046.pdf
0001087294-26-000046.rtf
0001087294-26-000046.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: 8-K
Description: Report of unscheduled material events or corporate event
Apr 24, 2026
View HTML
0001087294-26-000043.pdf
0001087294-26-000043.rtf
0001087294-26-000043.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: DEFA14A
Description: Additional proxy soliciting materials - definitive
Apr 23, 2026
View HTML
0001104659-26-047338.pdf
0001104659-26-047338.rtf
0001104659-26-047338.xls
Form: 8-K
Description: Report of unscheduled material events or corporate event
Apr 23, 2026
View HTML
0001104659-26-047335.pdf
0001104659-26-047335.rtf
0001104659-26-047335.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: 4
Description: Statement of changes in beneficial ownership of securities
BITTERMAN CHRIS T.
Mar 20, 2026
View HTML
0001087294-26-000034.pdf
0001087294-26-000034.rtf
0001087294-26-000034.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
KAZIMI A J
Mar 20, 2026
View HTML
0001087294-26-000032.pdf
0001087294-26-000032.rtf
0001087294-26-000032.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
HAMM JOHN M.
Mar 20, 2026
View HTML
0001087294-26-000033.pdf
0001087294-26-000033.rtf
0001087294-26-000033.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
Herman James L
Mar 20, 2026
View HTML
0001572342-26-000002.pdf
0001572342-26-000002.rtf
0001572342-26-000002.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
ANTHONY TODD M.
Mar 20, 2026
View HTML
0001087294-26-000035.pdf
0001087294-26-000035.rtf
0001087294-26-000035.xls
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »
Displaying 1 - 10 of 435 results

Data provided by Kaleidoscope.

© 2026 Cumberland Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy
Accessibility Statement
Terms of Use